News ReleasesRSS
- Jun 18, 2019 Anti-Cancer Agent Rozlytrek, Approved for the Treatment of NTRK Fusion Gene Positive Advanced/Recurrent Solid Tumors
- Jun 14, 2019 Chugai and Mitsubishi Logistics Enter into Service Agreement for Logistics Operations
- Jun 03, 2019 Chugai Files for Additional Indication of ALK Inhibitor ALECENSA for Recurrent or Refractory ALK Fusion Gene-Positive Anaplastic Large Cell Lymphoma (ALCL)
- Jun 03, 2019 Chugai Launches Genomic Mutation Analysis Program, FoundationOne CDx Cancer Genomic Profile
- Jun 03, 2019 Final Progression-Free Survival Data and the Second Interim Analysis of Overall Survival from the J-ALEX Study for Alecensa Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
What's NewRSS
- Jun 25, 2019 Events & Presentations has been updated with the Date of the Financial Results for 2Q (Jan-Jun 2019)
- Jun 19, 2019 Webcast of ESG Meeting
- Jun 18, 2019 ESG Meeting
- Apr 25, 2019 Webcast of 1Q Results (Jan-Mar 2019) Conference Call
- Apr 24, 2019 1Q Results (Jan-Mar 2019) Conference Call
Share price
Pick Up
For more information
Aiming to be a company where everyone can shine
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Biology Lab Classes for Children Held (2018)
-
Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge
-
Chugai to Take Part in Relay for Life Japan 2018
